• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

翻译后修饰与肿瘤代谢重编程。

Post-translational modifications and the reprogramming of tumor metabolism.

作者信息

Hu Yuqing, Xu Wenxia, Chen Lin

机构信息

Central Laboratory and Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang Province, China.

Jinhua Key Laboratory of Cancer Nutrition and Metabolism Research, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang Province, China.

出版信息

Discov Oncol. 2025 May 26;16(1):929. doi: 10.1007/s12672-025-02674-1.

DOI:10.1007/s12672-025-02674-1
PMID:40418495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12106264/
Abstract

Metabolic reprogramming occurs alongside tumor development. As cancers advance from precancerous lesions to locally invasive tumors and then to metastatic tumors, metabolic patterns exhibit distinct changes, including mutations in metabolic enzymes and modifications in the activity of metabolic regulatory proteins. Alterations in metabolic patterns can influence tumor evolution, either establishing or alleviating metabolic burdens and facilitating cancer growth. To fully understand how metabolic reprogramming helps tumors grow and find the metabolic activities that are most useful for treating tumors, we need to have a deeper understanding of how metabolic patterns are controlled as tumors grow. Post-translational modifications (PTMs), a critical mechanism in the regulation of protein function, can influence protein activity, stability, and interactions in several ways. In tumor cells, PTMs-mediated metabolic reprogramming is a crucial mechanism for adapting to the challenging microenvironment and sustaining fast growth. This article will deeply explore the intricate regulatory mechanism of PTMs on metabolic reprogramming and its role in tumor progression, with the expectation of providing new theoretical basis and potential targets for tumor treatment.

摘要

代谢重编程与肿瘤发展同步发生。随着癌症从前体病变发展为局部浸润性肿瘤,进而发展为转移性肿瘤,代谢模式呈现出明显变化,包括代谢酶的突变以及代谢调节蛋白活性的改变。代谢模式的改变可影响肿瘤进展,既可能加重也可能减轻代谢负担并促进癌症生长。为了全面了解代谢重编程如何助力肿瘤生长并找出对治疗肿瘤最有用的代谢活动,我们需要更深入地了解随着肿瘤生长代谢模式是如何被调控的。翻译后修饰(PTMs)作为调节蛋白质功能的关键机制,可通过多种方式影响蛋白质活性、稳定性及相互作用。在肿瘤细胞中,PTMs介导的代谢重编程是适应具有挑战性的微环境并维持快速生长的关键机制。本文将深入探讨PTMs对代谢重编程的复杂调控机制及其在肿瘤进展中的作用,以期为肿瘤治疗提供新的理论依据和潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/12106264/a34318493ffd/12672_2025_2674_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/12106264/a9e8fe5d5204/12672_2025_2674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/12106264/a34318493ffd/12672_2025_2674_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/12106264/a9e8fe5d5204/12672_2025_2674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ea/12106264/a34318493ffd/12672_2025_2674_Fig2_HTML.jpg

相似文献

1
Post-translational modifications and the reprogramming of tumor metabolism.翻译后修饰与肿瘤代谢重编程。
Discov Oncol. 2025 May 26;16(1):929. doi: 10.1007/s12672-025-02674-1.
2
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer.蛋白质的翻译后修饰调控癌症的所有特征。
Life (Basel). 2025 Jan 18;15(1):126. doi: 10.3390/life15010126.
3
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors.二甲双胍调控恶性肿瘤代谢重编程的研究进展。
Pharm Res. 2024 Nov;41(11):2143-2159. doi: 10.1007/s11095-024-03783-2. Epub 2024 Oct 25.
4
Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.肝癌中翻译后修饰的复杂作用:从机制到临床应用。
J Transl Med. 2024 Jul 13;22(1):651. doi: 10.1186/s12967-024-05455-6.
5
Metabolic reprogramming shapes post-translational modification in macrophages.代谢重编程塑造巨噬细胞中的翻译后修饰。
Mol Aspects Med. 2025 Apr;102:101338. doi: 10.1016/j.mam.2025.101338. Epub 2025 Feb 19.
6
Regulation of tumor metabolism by post translational modifications on metabolic enzymes.翻译:代谢酶的翻译后修饰对肿瘤代谢的调控。
Cancer Gene Ther. 2023 Apr;30(4):548-558. doi: 10.1038/s41417-022-00521-x. Epub 2022 Aug 23.
7
Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer.癌症中中心碳代谢酶的转录后和翻译后调控
Anticancer Agents Med Chem. 2017 Nov 24;17(11):1456-1465. doi: 10.2174/1871520617666170327110712.
8
Posttranslational control of lipogenesis in the tumor microenvironment.肿瘤微环境中脂肪生成的翻译后调控。
J Hematol Oncol. 2022 Aug 29;15(1):120. doi: 10.1186/s13045-022-01340-1.
9
The role of acetylation and deacetylation in cancer metabolism.乙酰化和去乙酰化在癌症代谢中的作用。
Clin Transl Med. 2025 Jan;15(1):e70145. doi: 10.1002/ctm2.70145.
10
Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells.长链非编码RNA在胃肠道癌细胞代谢重编程中的作用
Cancer Cell Int. 2024 Jan 6;24(1):15. doi: 10.1186/s12935-023-03194-0.

引用本文的文献

1
Genome-Wide Characterization of the Phosphofructokinase Gene Family in and Functional Analysis of AtPFK2 in Stress Tolerance.拟南芥中磷酸果糖激酶基因家族的全基因组特征分析及AtPFK2在抗逆性中的功能分析
Int J Mol Sci. 2025 Jul 16;26(14):6828. doi: 10.3390/ijms26146828.

本文引用的文献

1
Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies.癌症中的乳酸化修饰:机制、功能及治疗策略。
Exp Hematol Oncol. 2025 Mar 8;14(1):32. doi: 10.1186/s40164-025-00622-x.
2
Lactate and lactylation in cancer.癌症中的乳酸与乳酸化
Signal Transduct Target Ther. 2025 Feb 12;10(1):38. doi: 10.1038/s41392-024-02082-x.
3
GUK1 activation is a metabolic liability in lung cancer.GUK1激活是肺癌中的一种代谢负担。
Cell. 2025 Mar 6;188(5):1248-1264.e23. doi: 10.1016/j.cell.2025.01.024. Epub 2025 Feb 6.
4
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.TTI-101(一种首创的STAT3口服抑制剂)用于晚期实体瘤患者的I期试验。
Clin Cancer Res. 2025 Mar 17;31(6):965-974. doi: 10.1158/1078-0432.CCR-24-2920.
5
Tanshinone I reprograms glycolysis metabolism to regulate histone H3 lysine 18 lactylation (H3K18la) and inhibits cancer cell growth in ovarian cancer.丹参酮I重编程糖酵解代谢以调节组蛋白H3赖氨酸18乳酸化(H3K18la)并抑制卵巢癌细胞生长。
Int J Biol Macromol. 2025 Feb;291:139072. doi: 10.1016/j.ijbiomac.2024.139072. Epub 2024 Dec 20.
6
VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN.VCP 通过招募 USP2 来抑制 FASN 的泛素化和降解,从而增强与自噬相关的骨肉瘤的进展。
Cell Death Dis. 2024 Nov 3;15(11):788. doi: 10.1038/s41419-024-07168-6.
7
Dexmedetomidine inhibits the migration, invasion, and glycolysis of glioblastoma cells by lactylation of c-myc.右美托咪定通过 c-myc 的乳酰化抑制胶质母细胞瘤细胞的迁移、侵袭和糖酵解。
Neurol Res. 2024 Dec;46(12):1105-1112. doi: 10.1080/01616412.2024.2395069. Epub 2024 Aug 28.
8
Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer.SIAH1 缺乏通过增加 FASN 在肝癌中的积累促进了伪足的形成。
Cell Death Dis. 2024 Jul 29;15(7):537. doi: 10.1038/s41419-024-06929-7.
9
NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance.高效的DNA修复和化疗耐药性需要NBS1乳酸化。
Nature. 2024 Jul;631(8021):663-669. doi: 10.1038/s41586-024-07620-9. Epub 2024 Jul 3.
10
TMEM52B Isoforms P18 and P20 Differentially Promote the Oncogenesis and Metastasis of Nasopharyngeal Carcinoma.TMEM52B 异构体 P18 和 P20 差异促进鼻咽癌的发生和转移。
Adv Sci (Weinh). 2024 Sep;11(33):e2402457. doi: 10.1002/advs.202402457. Epub 2024 Jun 28.